Other cancers

Companies

• AbCellera Biologics (ABCL)Thesis Intact

  Cancer, Oncology

• Abeona Therapeutics (ABEO)Thesis Intact

  Prostate cancer

• Acrivon Therapeutics (ACRV)Thesis Intact

  Solid tumors

• Actinium Pharmaceuticals (ATNM)Thesis Challenged

  Solid tumors, Prostate cancer

• Adagene (ADAG)Thesis Intact

  Solid tumors

• ADC Therapeutics SA (ADCT)Thesis Challenged

  Metastatic castrate-resistant prostate cancer

• Alpha Tau Medical (DRTS)Thesis Intact

  Glioblastoma, Prostate cancer, Cutaneous squamous cell carcinoma, Head and neck squamous cell carcinoma

• ALX Oncology (ALXO)Thesis Challenged

  Solid tumors, EGFR-expressing solid tumors

• Arcus Biosciences (RCUS)Thesis Intact

  Clear cell renal cell carcinoma

• Artiva Biotherapeutics (ARTV)Thesis Intact

  Solid tumors

• Ascendis Pharma (ASND)Thesis Challenged

  Cancer

• Bicycle Therapeutics (BCYC)Thesis Challenged

  Cancer, Solid tumors, Urothelial cancer

• Biohaven (BHVN)Thesis Challenged

  Solid tumors

• Black Diamond Therapeutics (BDTX)Thesis Intact

  Glioblastoma, Fgfr2/3-mutant cancers

• BridgeBio Oncology Therapeutics (BBOT)Thesis Intact

  Solid tumors, KRAS-mutant cancers

• Calidi Biotherapeutics (CLDI)Thesis Challenged

  Glioma, Solid tumor, Soft tissue sarcoma, Head and neck cancer

• Candel Therapeutics (CADL)Thesis Intact

  Glioma, Solid tumors, Prostate cancer, Recurrent glioblastoma, and 1 more

• Cellectar Biosciences (CLRB)Thesis Challenged

  High-grade glioma

• Coherus Oncology (CHRS)Thesis Challenged

  Solid tumors, Prostate cancer, Nasopharyngeal carcinoma, Head and neck squamous cell carcinoma, and 1 more

• Compass Therapeutics (CMPX)Thesis Challenged

  Solid tumors, Tumors with NCAM/CD56 expression

• Context Therapeutics (CNTX)Thesis Intact

  Urothelial cancer, Testicular cancer, Urothelial carcinoma

• Corbus Pharmaceuticals (CRBP)Thesis Intact

  HNSCC, OPSCC, Solid tumors, Metastatic urothelial carcinoma, and 2 more

• Corvus Pharmaceuticals (CRVS)Thesis Intact

  Solid tumors, Renal cell carcinoma

• CytomX Therapeutics (CTMX)Thesis Intact

  Melanoma

• Delcath Systems (DCTH)Thesis Intact

  Uveal melanoma

• enGene Therapeutics (ENGN)Thesis Challenged

  NMIBC, NMIBC with CIS, Non-muscle invasive bladder cancer with carcinoma in situ

• Erasca (ERAS)Thesis Intact

  Solid tumors, RAS-mutant solid tumors, KRAS-mutant solid tumors

• Evaxion (EVAX)Thesis Intact

  Melanoma, Glioblastoma

• Faeth Therapeutics (FTH)Thesis Intact

  Cancer

• Harrow (HROW)Thesis Challenged

  Ocular neoplasia

• IDEAYA Biosciences (IDYA)Thesis Intact

  Solid tumors, Uveal melanoma, Prostate cancer, Urothelial cancer, and 5 more

• Immatics (IMTX)Thesis Intact

  Melanoma, Solid tumors, Uveal melanoma, Synovial sarcoma, and 2 more

• Immuneering (IMRX)Thesis Intact

  Solid tumors

• ImmunityBio (IBRX)Thesis Intact

  NMIBC, Glioblastoma, Non-muscle invasive bladder cancer, Bcg-naive non-muscle invasive bladder cancer

• Immunocore (IMCR)Thesis Intact

  Solid tumors, Advanced cancers, Cutaneous melanoma, Multiple solid tumors, and 1 more

• Immutep (IMMP)Thesis Challenged

  Soft tissue sarcoma, Head and neck squamous cell carcinoma

• INmune Bio (INMB)Thesis Challenged

  Prostate cancer

• Iovance Biotherapeutics (IOVA)Thesis Intact

  Sarcoma, Melanoma, Solid tumors, Renal cell carcinoma, and 2 more

• MAIA Biotechnology (MAIA)Thesis Challenged

  Pediatric-type diffuse high-grade gliomas

• Moleculin Biotech (MBRX)Thesis Challenged

  Brain tumor, Brain tumors, Soft tissue sarcoma

• Monte Rosa Therapeutics (GLUE)Thesis Intact

  Solid tumor, Solid tumors, Advanced CRPC, Prostate cancer, and 2 more

• Nektar Therapeutics (NKTR)Thesis Intact

  Urothelial carcinoma

• Neuphoria Therapeutics (NEUP)Thesis Challenged

  Advanced melanoma

• NextCure (NXTC)Thesis Broken

  Cancer, Solid tumors, Multiple cancers

• NovoCure (NVCR)Thesis Challenged

  Glioblastoma

• Nuvectis Pharma (NVCT)Thesis Intact

  Advanced solid tumors, BRAF-mutated solid tumors

• ORIC Pharmaceuticals (ORIC)Thesis Intact

  MCRPC, Cancer, Homologous recombination deficient cancer, Metastatic castration-resistant prostate cancer

• OS Therapies (OSTX)Thesis Challenged

  Osteosarcoma, Pediatric osteosarcoma, Castration-resistant prostate cancer

• Passage Bio (PASG)Thesis Broken

  Adenoid Cystic Carcinoma

• Perspective Therapeutics (CATX)Thesis Intact

  Melanoma, Solid tumors, Multiple solid tumors, Neuroendocrine tumors, and 3 more

• Pliant Therapeutics (PLRX)Thesis Intact

  Solid tumor, Solid tumors

• PolyPid (PYPD)Thesis Intact

  Solid tumor, Glioblastoma

• Precigen (PGEN)Thesis Intact

  Oropharyngeal cancer, Newly diagnosed HPV-associated oropharyngeal cancer

• Profound Medical (PROF)Thesis Intact

  Desmoid tumor, Prostate cancer, Bone metastases, Abdominal cancer

• Protara Therapeutics (TARA)Thesis Intact

  Non-muscle invasive bladder cancer

• Pyxis Oncology (PYXS)Thesis Challenged

  R/M HNSCC, Head and neck squamous cell carcinoma

• Radiopharm Theranostics (RADX)Thesis Challenged

  Prostate cancer, Brain metastases, Advanced solid tumors, PD-L1 positive cancers, and 2 more

• Recursion Pharmaceuticals (RXRX)Thesis Intact

  Oncology, Solid tumors, PI3K H1047R mutant solid tumors

• Replimune Group (REPL)Thesis Challenged

  Melanoma, Uveal melanoma, Cutaneous squamous cell carcinoma

• Summit Therapeutics (SMMT)Thesis Challenged

  Urothelial carcinoma, Multiple cancer types, Clear cell renal cell carcinoma, Head and neck squamous cell carcinoma

• Tango Therapeutics (TNGX)Thesis Intact

  Glioblastoma

• Tonix Pharmaceuticals (TNXP)Thesis Challenged

  Immuno-oncology (multiple cancers)

• TransCode Therapeutics (RNAZ)Thesis Challenged

  Cancer, Melanoma, Solid tumors, Muscle-invasive bladder cancer

• TScan Therapeutics (TCRX)Thesis Challenged

  Solid tumors

• Verastem (VSTM)Thesis Intact

  Advanced KRAS G12D-mutant solid tumors

Drug pages

IvonescimabANKTIVA (nogapendekin alfa inbakicept)LifileucelVusolimogene oderparepvec (RP1)

Upcoming catalysts